These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 11368440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C, Nielsen M, Kaltoft K, Mikkelsen G, Zhang Q, Wasik M, Billestrup N, Odum N.
    Blood; 2001 Feb 15; 97(4):1056-62. PubMed ID: 11159537
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.
    Nielsen M, Kaltoft K, Nordahl M, Röpke C, Geisler C, Mustelin T, Dobson P, Svejgaard A, Odum N.
    Proc Natl Acad Sci U S A; 1997 Jun 24; 94(13):6764-9. PubMed ID: 9192639
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.
    Alas S, Bonavida B.
    Clin Cancer Res; 2003 Jan 24; 9(1):316-26. PubMed ID: 12538484
    [Abstract] [Full Text] [Related]

  • 6. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis.
    Bright JJ, Du C, Sriram S.
    J Immunol; 1999 May 15; 162(10):6255-62. PubMed ID: 10229872
    [Abstract] [Full Text] [Related]

  • 7. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
    Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A, Jove R.
    Oncogene; 2001 May 03; 20(20):2499-513. PubMed ID: 11420660
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
    Spiekermann K, Biethahn S, Wilde S, Hiddemann W, Alves F.
    Eur J Haematol; 2001 Aug 03; 67(2):63-71. PubMed ID: 11722592
    [Abstract] [Full Text] [Related]

  • 10. Contribution of STAT3 and RAD23B in Primary Sézary Cells to Histone Deacetylase Inhibitor FK228 Resistance.
    Butler RM, McKenzie RC, Jones CL, Flanagan CE, Woollard WJ, Demontis M, Ferreira S, Tosi I, John S, Whittaker SJ, Mitchell TJ.
    J Invest Dermatol; 2019 Sep 03; 139(9):1975-1984.e2. PubMed ID: 30910759
    [Abstract] [Full Text] [Related]

  • 11. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q, Lee B, Korecka M, Li G, Weyland C, Eck S, Gessain A, Arima N, Lessin SR, Shaw LM, Luger S, Kamoun M, Wasik MA.
    Leuk Res; 1999 Apr 03; 23(4):373-84. PubMed ID: 10229324
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of constitutively active Stat3 suppresses growth of human ovarian and breast cancer cells.
    Burke WM, Jin X, Lin HJ, Huang M, Liu R, Reynolds RK, Lin J.
    Oncogene; 2001 Nov 29; 20(55):7925-34. PubMed ID: 11753675
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
    van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH, Willemze R, Tensen CP, Vermeer MH.
    J Invest Dermatol; 2011 Mar 29; 131(3):762-8. PubMed ID: 21085192
    [Abstract] [Full Text] [Related]

  • 14. JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells.
    De Vos J, Jourdan M, Tarte K, Jasmin C, Klein B.
    Br J Haematol; 2000 Jun 29; 109(4):823-8. PubMed ID: 10929036
    [Abstract] [Full Text] [Related]

  • 15. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells.
    Zhang C, Li B, Gaikwad AS, Haridas V, Xu Z, Gutterman JU, Duvic M.
    J Invest Dermatol; 2008 Nov 29; 128(11):2728-2735. PubMed ID: 18496567
    [Abstract] [Full Text] [Related]

  • 16. EPHA4 is overexpressed but not functionally active in Sézary syndrome.
    Hameetman L, van der Fits L, Zoutman WH, Out-Luiting JJ, Siegal G, de Esch IJ, Vermeer MH, Tensen CP.
    Oncotarget; 2015 Oct 13; 6(31):31868-76. PubMed ID: 26376612
    [Abstract] [Full Text] [Related]

  • 17. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
    J Immunol; 1999 Apr 01; 162(7):3897-904. PubMed ID: 10201908
    [Abstract] [Full Text] [Related]

  • 18. Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sézary syndrome.
    van der Fits L, Out-Luiting JJ, van Leeuwen MA, Samsom JN, Willemze R, Tensen CP, Vermeer MH.
    J Invest Dermatol; 2012 Feb 01; 132(2):440-7. PubMed ID: 21938013
    [Abstract] [Full Text] [Related]

  • 19. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.
    Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernández-Luna JL, Nuñez G, Dalton WS, Jove R.
    Immunity; 1999 Jan 01; 10(1):105-15. PubMed ID: 10023775
    [Abstract] [Full Text] [Related]

  • 20. Tyrosine kinase inhibitor tyrphostin AG490 triggers both apoptosis and autophagy by reducing HSF1 and Mcl-1 in PEL cells.
    Granato M, Chiozzi B, Filardi MR, Lotti LV, Di Renzo L, Faggioni A, Cirone M.
    Cancer Lett; 2015 Oct 01; 366(2):191-7. PubMed ID: 26184999
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.